Thermography, an ideal screening tool for breast cancer

NewsGuard 100/100 Score

Thermographic Diagnostic Imaging (TDI), part of a Health & Wellness Center in Marlton, New Jersey continues to provide superior quality infrared imaging of the breast, neuromuscular system, thyroid, dental, TMJ and sinus regions to assist in the early diagnosis of problems associated with these areas.

Thermography utilizes infrared imaging cameras that "read" the entire infrared range of the electromagnetic spectrum and produce images. Medical Thermography uses infrared technology to provide an image of the body's physiological responses. It does so without the use of radiation, contact or other invasive means. There are no risks or side effects to the test.

TDI utilizes the NEC Thermo Tracer by Mikron, the only FDA approved unit expressly designed for medical applications. It is considered by many to be the finest thermal imaging camera available due to its lack of drift leading to highly reproducible serial studies. Not all Thermographic equipment is of this quality. Some units do not allow for variable statistical measurement of regions of interest.

"It is imperative that the interpreter 'mark up' the images not only to compare contralateral temperatures but also to assure that the same points can be measured in all future studies," explains Dr. Philip Getson. "Additionally each breast study should be a 'full study' with at least nine views in black and white and nine color images. A cold challenge should also be employed in all breast studies," he adds.

TDI strictly adheres to protocols of the world wide Thermographic community. All images are taken in controlled environments with special attention to temperature and ambient light. As a part of patient centered approach all abnormal reports are followed up with a phone conference with Dr. Getson at which time the images are reviewed and recommendations made. These may include further diagnostic tests as well nutritional and dietary counseling, detoxification and other approaches to health.

"Thermography is a totally safe, non-radiologic, non-invasive, painless test with absolutely no adverse effects and NO contraindications," explains Liesha Getson. "It can be used at any age and provides a diagnostic tool far superior to others in early stages of some diseases, while being equally effective at any stage of the disease process," she adds.

It is well documented in all fields of medicine that the earliest detection leads to the best outcome. In this highly technological era where patients are becoming better informed and more pro-active with regard to their health, Thermography offers a safe means of early detection.

All of this information has become even more important in light of recent events surrounding the use of mammography and the position of the American Cancer Society.

As explained in a front page article of The New York Times on October 20, 2009, Dr. Otis Brawley, Chief Medical Officer of the Society stated that the "medical profession had exaggerated the benefit of cancer screening."

While the Society continues to recommend mammograms, there is debate as to their effectiveness in the diagnosis of breast cancer. They issued a statement saying: "mammography can miss cancers that need treatment, and in some cases, finds disease that does not need treatment."

More recently, on November 16, 2009 the U.S. Preventative Services Task Force Breast Cancer Screening Recommendations for the General Public was released, changing a long standing position regarding mammography. Their new recommendations include:

  • Begin screening at age 50 (formerly 40)
  • Screen every other year (formerly annually)
  • No screening after age 75
  • Physicians should stop teaching self exam
  • Benefit of physician-based physical exams was questioned

Interestingly, the USPSTF's evaluation stated that, "Rather than benefit from screening, women without cancer may incur harm when undergoing mammography, additional imaging, and biopsies."

Then why not Thermography? Studies have shown that Thermography has a higher degree of success in identifying breast cancer in women under the age of 55 and has been shown to be extremely effective when combined with clinical breast exams and anatomic testing for women over 55. Moreover it provides a completely safe and non-invasive baseline against which future scans can be compared for the ongoing monitoring of breast health.

According to a report in Time Magazine on April 28, 2003 the American Cancer Society is quoted: "Breast cancer is the leading cause of death in women between the ages of 40 and 44." Therefore screening should begin on women in their early twenties, since most lethal breast cancers can take approximately 15 years from onset to time of death. Because of its safety factor and sensitivity, this makes Thermography the IDEAL screening tool.

Comments

  1. Helen Schulman Helen Schulman United States says:

    I'm dying to find some research studies that compares thermography to mammography in terms of how successfully each methodology is able to find breast cancer.  If there are such studies out there, please let me know how I can access them.  I'm afraid of mammography at this point, but don't fully trust thermography unless I see evidence from comparative studies on its effectiveness.

  2. k k United States says:

    While a lot of the information pertained in this article is correct.  the quote "TDI utilizes the NEC Thermo Tracer by Mikron, the only FDA approved unit expressly designed for medical applications."  is a blatant lie.  Our company sells these cameras and they are not approved nor are they cleared for medical use in the USA.

  3. Mary Quigley Mary Quigley United Kingdom says:

    My daughter is undergoing PARP11 trials in Mount Vernon for invasive, aggressive BRCA 2 ER - Receptor Breast Cancer + Lymphnodes + Bones + Liver metastases. The PARP is making the Bone cancer spread further because she is now in pain and she was free of pain previously, from the base of her skull to her hips.   She has stage IV cancer since early 2004, and the medical profession are astounded she is still alive.  They said, "had you asked we would have said:you have less than one year" I need to know whether Bio-Bran will help to improve her condition or should I try to get "Avemar" some way.  Not being a professional person myself I find it very difficult to get what I need for my daughter. The latin proverb of "primum non nocere" does not seem to be operative anymore, while my daughter is left to die but not if I can help it. If needs be I have and will still further go through hell for her. Please if you are not afraid of the pharmaceuticals-HELP.  From Mary.

  4. Gary Strahan Gary Strahan United States says:

    I forwarded this link to doctor Lynch. I am the CEO of Infrared Cameras Inc. Please visit www.medicalir.com and www.infraredcamerasinc.com. We have FDA 510K Clearance and a wealth of information for you. My phone number is 713-859-3599, Thank you, Gary Strahan

  5. Gary Strahan Gary Strahan United States says:

    Dr. Philip Getson. I would appreciate it if you would recant your above article. Please give me a call at 713-859-3599 or e-mail me at [email protected]. Our legal team will be in touch.

    Thank you, Gary Strahan

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer